Skip to content
OpenCapital
Get started

IQVIA IQV Research & Development Solutions — Revenue

Other segment segments

Commercial Solutions
$1.75B—

Similar metrics at other companies

AMP
AMPHResearch And Development Services — Revenue
$2.5M+2,400%
Arcus Biosciences logo
RCUSR&D services — Total revenues
$2M0.0%
Kopin logo
KOPNResearch And Development Revenues — Revenue
$1.29M+4.3%
Ionis Pharmaceuticals logo
IONSResearch And Development Revenue — Revenue
$138.28M+149%
Sutro Biopharma logo
STROResearch And Development Services — Revenue
$556K-38.1%
Nuvation Bio logo
NUVBResearch And Development Service Revenue — Revenue
$700K-63.2%

Other financials

Income statement

See full
Revenue$4.2B+8.4%
Gross profit$1.4B+4.4%
Operating income$514.0M+3.6%
Net income$274.0M+10.0%
EPS (diluted)$1.61+15.0%

Balance sheet

See full
Cash & equivalents$1.9B+11.9%
Total debt$16.1B+10.7%
Total equity$6.2B+4.1%
Total assets$29.7B+8.6%

Cash flow

See full
Operating cash flow$618.0M+8.8%
CapEx$127.0M-10.6%
Free cash flow$491.0M+15.3%

Valuation

See full
Market cap$32.25B+17.5%
Enterprise value$46.37B+12.8%
P/E23.3×+1.1×
P/S1.9×+0.2×

Profitability

See full
Gross margin33%-1.7pp
Operating margin13.2%-0.9pp
Net margin8.3%-0.3pp
FCF margin12.7%-1.2pp

Returns & leverage

See full
Return on equity22.7%+1.1pp
Debt / equity2.6×+0.2×
Current ratio0.7×-0.1×

Where this comes from

Reported directly by IQVIA in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: IQVIA’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about IQVIA's research & development solutions — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is IQVIA's research & development solutions — revenue?
IQVIA (IQV) reported research & development solutions — revenue of $2.4B in Q1 2026.
How has IQVIA's research & development solutions — revenue changed year-over-year?
IQVIA's research & development solutions — revenue increased by 6.2% year-over-year, from $2.26B to $2.4B.
What is the long-term trend for IQVIA's research & development solutions — revenue?
Over 4 years (2021 to 2025), IQVIA's research & development solutions — revenue has grown at a 4.6% compound annual growth rate (CAGR), from $7.56B to $9.05B.
What does research & development solutions — revenue mean?
Represents the total gross income generated by the contract research organization segment through the provision of clinical trial services and drug development support to pharmaceutical and biotechnology clients. This metric reflects the scale of outsourced R&D activities and the company's ability to capture market share in the clinical research services industry.